Molecular challenges imposed by MHC-I restricted long epitopes on T cell immunity

被引:27
|
作者
Josephs, Tracy M. [1 ,2 ,3 ]
Grant, Emma J. [1 ,2 ,4 ]
Gras, Stephanie [1 ,2 ,3 ]
机构
[1] Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic 3800, Australia
[2] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic 3800, Australia
[3] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia
[4] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales
基金
澳大利亚研究理事会; 英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
antigen presentation; human leukocyte antigen; major histocompatibility complex; T cell receptor recognition; tumor peptide; viral peptide; COMPLEX CLASS-I; BULGED VIRAL PEPTIDE; HLA MICROPOLYMORPHISM; RECEPTOR RECOGNITION; IMPACT; REPERTOIRE; RESPONSES; SELF; IMMUNODOMINANCE; SPECIFICITY;
D O I
10.1515/hsz-2016-0305
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has widely been accepted that major histocompatibility complex class I molecules (MHC-I) are limited to binding small peptides of 8-10 residues in length. However, this consensus has recently been challenged with the identification of longer peptides (>= 11 residues) that can also elicit cytotoxic CD8 (+) T cell responses. Indeed, a growing number of studies demonstrate that these non-canonical epitopes are important targets for the immune system. As long epitopes represent up to 10% of the peptide repertoire bound to MHC-I molecules, here we review their impact on antigen presentation by MHC-I, TCR recognition, and T cell immunity.
引用
收藏
页码:1027 / 1036
页数:10
相关论文
共 50 条
  • [21] A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma
    Capasso, Cristian
    Magarkar, Aniket
    Cervera-Carascon, Victor
    Fusciello, Manlio
    Feolaf, Sara
    Muller, Martin
    Garofalo, Mariangela
    Kuryk, Lukasz
    Tahtinen, Siri
    Pastore, Lucio
    Bunker, Alex
    Cerullo, Vincenzo
    ONCOIMMUNOLOGY, 2017, 6 (09):
  • [22] Hydrophobicity is a hallmark of immunogenic MHC class I T cell epitopes
    Chowell, Diego
    Krishna, Sri
    Blattman, Joseph
    Anderson, Karen
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [23] Molecular machinations of the MHC-I peptide loading complex
    Purcell, Anthony W.
    Elliott, Tim
    CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (01) : 75 - 81
  • [24] Contribution of lateral dynamics of MHC-I molecules in effector T cell target cell interactions
    Kwik, J
    Edidin, M
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 211A - 211A
  • [25] Role of nonpolymorphic MHC-I and innate T cells in Xenopus larval resistance and tolerigenic immunity to mycobacteria
    Pavelka, Martin
    Andino, Francisco De Jesus
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [26] Oncolytic adenovirus loaded with MHC-I restricted peptide as platform for oncolytic vaccine
    Capasso, Cristian
    Garofalo, Mariangela
    Hirvinen, Mari
    Romanyuk, Dmitry
    Kuryk, Lukasz
    Antopolsky, Maxim
    Vitala, Tapani
    Urtti, Arto
    Cerullo, Vincenzo
    HUMAN GENE THERAPY, 2014, 25 (11) : A29 - A30
  • [27] Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells
    Frisan, T
    Zhang, QJ
    Levitskaya, J
    Coram, M
    Kurilla, MG
    Masucci, MG
    INTERNATIONAL JOURNAL OF CANCER, 1996, 68 (02) : 251 - 258
  • [28] Positional Bias of MHC Class I Restricted T-Cell Epitopes in Viral Antigens Is Likely due to a Bias in Conservation
    Kim, Yohan
    Yewdell, Jonathan W.
    Sette, Alessandro
    Peters, Bjoern
    PLOS COMPUTATIONAL BIOLOGY, 2013, 9 (01)
  • [29] Oncolytic Adenovirus Loaded with MHC-I Restricted Peptide as Platform for Oncolytic Vaccine
    Capasso, Cristian
    Mari, Hirvinen
    Mariangela, Garofalo
    Romanyuk, Dmitry
    Kuryk, Lukasz
    Antopolsky, Maxim
    Urtti, Arto
    Cerullo, Vincenzo
    MOLECULAR THERAPY, 2014, 22 : S190 - S191
  • [30] Predicting T cell recognition of MHC class I restricted neoepitopes
    Kosaloglu-Yalcin, Zeynep
    Lanka, Manasa
    Frentzen, Angela
    Premlal, Ashmitaa Logandha Ramamoorthy
    Sidney, John
    Vaughan, Kerrie
    Greenbaum, Jason
    Robbins, Paul
    Gartner, Jared
    Sette, Alessandro
    Peters, Bjoern
    ONCOIMMUNOLOGY, 2018, 7 (11):